Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in NBIX — Neurocrine Biosciences Inc

CIK 902219 Boston, MA

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$183,057,866
-$64,373,077 QoQ
Shares Held
1,389,539
-20.4% QoQ
Ownership
1.38%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 81.81029823560188.ToString("F0")% None 18.18970176439812.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $3,311,744,758 across 31 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
1,389,539 $183,057,866

All Filings in NBIX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $183,057,866 1,389,539
2025-12-31 $247,430,943 1,744,560
2025-09-30 $254,335,147 1,811,762
2025-06-30 $255,007,160 2,028,858
2025-03-31 $232,036,697 2,097,981
2024-12-31 $198,938,510 1,457,425
2024-09-30 $82,753,996 718,226
2024-06-30 $123,833,198 899,493
2024-03-31 $138,437,198 1,003,750
2023-12-31 $158,051,650 1,199,542
2023-09-30 $149,393,136 1,327,939
2023-06-30 $131,967,095 1,399,439
2023-03-31 $118,533,273 1,171,046
2022-12-31 $144,050,966 1,206,053
2022-09-30 $81,723,281 769,450
2022-06-30 $43,295,640 444,149
2022-03-31 $36,506,998 389,408
2021-09-30 $2,496,440 26,029
2021-06-30 $3,681,419 37,828
2021-03-31 $3,706,099 38,109
2020-12-31 $3,824,509 39,901
2020-09-30 $2,328,802 24,218
2020-06-30 $3,635,966 29,803
2020-03-31 $3,665,565 42,352